Loss of DSTYK activates Wnt/β-catenin signaling and glycolysis in lung adenocarcinoma
Open Access
- 1 December 2021
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (12) , 1-10
Abstract
Aberrant activation of Wnt/β-catenin signaling and dysregulation of metabolism have been frequently observed in lung cancer. However, the molecular mechanism by which Wnt/β-catenin signaling is regulated and the link between Wnt/β-catenin signaling and cancer metabolism are not fully understood. In this study, we showed that the loss of dual serine/threonine tyrosine protein kinase (DSTYK) led to the activation of Wnt/β-catenin signaling and upregulation of its target gene, lactate dehydrogenase (LDHA), and thus the elevation of lactate. DSTYK phosphorylated the N-terminal domain of β-catenin and inhibited Wnt/β-catenin signaling, which led to the inhibition of cell growth, colony formation and tumorigenesis in a lung adenocarcinoma mouse model. DSTYK was downregulated in lung cancer tissues, and its expression was positively correlated with the survival of patients with lung adenocarcinoma. Taken together, these results demonstrate that the loss of DSTYK activates Wnt/β-catenin/LDHA signaling to promote the tumorigenesis of lung cancer and that DSTYK may be a therapeutic target.Keywords
Funding Information
- National Natural Science Foundation of China (81401933)
- Nurture projects for basic research of Shanghai Chest Hospital
This publication has 31 references indexed in Scilit:
- Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cellsOncogene, 2017
- DSTYK kinase domain ablation impaired the mice capabilities of learning and memory in water maze test.2014
- Whack a gli hedgehogNature Reviews Clinical Oncology, 2014
- Mutations in DSTYK and Dominant Urinary Tract MalformationsNew England Journal of Medicine, 2013
- DSTYK gene linked to urinary tract defectsNature Reviews Urology, 2013
- Tankyrase-targeted therapeutics: expanding opportunities in the PARP familyNature Reviews Drug Discovery, 2012
- Wnt/β-catenin signalling in prostate cancerNature Reviews Urology, 2012
- Dusty protein kinases: Primary structure, gene evolution, tissue specific expression and unique features of the catalytic domainBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2006
- [Expression and mutation of ?-catenin in non-small cell lung cancer].2004
- Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase MechanismCell, 2002